**Episodic:**85 to 90% of patients. Patients experience daily attacks for weeks to months and then have a remission lasting months or years. Patients typically have 1 to 2 episodes yearly, most often in spring or autumn.

**Chronic:**15 to 20% of patients. Patients experience attacks lasting more than a year without remission or remission that lasts less than one month; 10 to 20% of these patients will develop drug resistance.

**Probable:**patients whose attacks fulfill all but one criterion.